Lyell Immunopharma says Matthew Lang, J.D. has joined as Chief Business Officer

Lyell Immunopharma announced that Matthew Lang, J.D. has joined the executive management team as Chief Business Officer. In this newly created role, Mr. Lang will serve on Lyell’s executive committee and will be responsible for Lyell’s legal, compliance, human resources, alliance management and early commercialization teams. He will also serve as Lyell’s Chief Legal Officer and Corporate Secretary. “Matt is an experienced company builder who has successfully led growth in complex organizations to realize the value of innovative medicines for patients and shareholders,” said Lynn Seely, M.D., Lyell’s President and CEO. “I am delighted to welcome him to the team as we advance our mission of unlocking the potential of cell therapy for patients with solid tumors.”